Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6197 results

On LGBTQ+ STEM day, we hear from two Cancer Research UK scientists on the power of diversity and why bringing your full self to your research is so important… On LGBTQ+ STEM day, we hear from two Cancer Research UK scientists on the power of diversity and why bringing your full self to your research is so important…

by Phil Prime | In depth | 18 November 2021

18 November 2021

This entry is part 6 of 10 in the series Diversity in research
%postcontent%
A photograph of a lady holding a vaccine and needle.

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide. We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

by Lilly Matson | In depth | 17 November 2021

17 November 2021

Some of the In2scienceUK mentors and mentees

We’ve partnered with In2science UK, an organisation that promotes diversity in STEM, to sponsor 10 young people through a mentoring programme. We’ve partnered with In2science UK, an organisation that promotes diversity in STEM, to sponsor 10 young people through a mentoring programme.

by Mae De Los Santos | In depth | 16 November 2021

16 November 2021

This entry is part 7 of 10 in the series Diversity in research
%postcontent%
Eithne Costello

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important. Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

by Phil Prime | Interview | 12 November 2021

12 November 2021

Lung cancer cells

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

by Harry Jenkins | News | 11 November 2021

11 November 2021

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation. Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation.

by Cancer Research UK | In depth | 5 November 2021

5 November 2021

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

by Phil Prime | Interview | 2 November 2021

2 November 2021

As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it. As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it.

by Emily Armstrong | In depth | 1 November 2021

1 November 2021

The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work? The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work?

by Oliver Buckley-Mellor | Analysis | 29 October 2021

29 October 2021